Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
8.68
+0.79 (10.01%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Vanda Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
513521279243418874
Upgrade
Market Cap Growth
95.97%86.62%15.04%-41.95%-52.16%21.63%
Upgrade
Enterprise Value
262238-89-237-25481
Upgrade
Last Close Price
8.688.824.794.227.3915.69
Upgrade
PE Ratio
---96.7766.6526.37
Upgrade
Forward PE
----21.7421.94
Upgrade
PS Ratio
2.372.411.411.261.643.25
Upgrade
PB Ratio
1.571.590.520.450.791.73
Upgrade
P/TBV Ratio
2.442.480.660.570.821.80
Upgrade
P/FCF Ratio
----13.3613.73
Upgrade
P/OCF Ratio
---18.9713.0813.61
Upgrade
EV/Sales Ratio
1.211.10---1.79
Upgrade
EV/EBITDA Ratio
-----10.69
Upgrade
EV/EBIT Ratio
-----11.41
Upgrade
EV/FCF Ratio
-----7.55
Upgrade
Debt / Equity Ratio
0.040.040.020.020.020.02
Upgrade
Debt / EBITDA Ratio
----0.950.26
Upgrade
Debt / FCF Ratio
----0.360.19
Upgrade
Net Debt / Equity Ratio
-0.77-0.77-0.67-0.69-0.86-0.83
Upgrade
Net Debt / EBITDA Ratio
1.761.7611.1434.62-50.29-9.34
Upgrade
Net Debt / FCF Ratio
2.282.2817.694.29-14.56-6.60
Upgrade
Asset Turnover
0.380.380.310.300.410.48
Upgrade
Inventory Turnover
7.297.297.3411.6021.8922.24
Upgrade
Quick Ratio
2.192.194.224.825.476.25
Upgrade
Current Ratio
2.392.394.394.945.686.43
Upgrade
Return on Equity (ROE)
-50.93%-50.93%-3.49%0.47%1.22%6.92%
Upgrade
Return on Assets (ROA)
-16.50%-16.50%-3.90%-1.36%0.64%4.68%
Upgrade
Return on Invested Capital (ROIC)
-116.68%-119.87%-23.76%-4.65%4.51%35.94%
Upgrade
Return on Capital Employed (ROCE)
-44.00%-44.00%-7.30%-2.50%1.20%8.10%
Upgrade
Earnings Yield
-42.97%-42.30%-6.77%1.03%1.50%3.79%
Upgrade
FCF Yield
-21.53%-21.19%-7.33%-36.35%7.49%7.28%
Upgrade
Buyback Yield / Dilution
-1.34%-1.34%-1.03%-1.01%-0.11%-3.14%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.